Biodistribution of, antimutagenic efficacies in Salmonella typhimurium of, and inhibition of P450 activities by ellagic acid and one analogue

Chemical Research in Toxicology

Volumn 11, Issue 11, 1998, Pages 1258-1264

  Castonguay, Andre ^a   Boukharta, Mohamed ^a   Teel, Robert ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMUTAGENIC AGENT; CYTOCHROME P450 INHIBITOR; ELLAGIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; ENZYME INHIBITION; FEMALE; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIMUTAGENIC AGENTS; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; ELLAGIC ACID; ENZYME INHIBITORS; LUNG; MICE; MICE, INBRED A; MICROSOMES; MUTATION; NITROSAMINES; SALMONELLA TYPHIMURIUM; TESTOSTERONE;

EID: 0031773508     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980033g     Document Type: Article

References (58)

1. USDA Economic Research Service (1988) Fruits and tree nuts: Situation and outlook yearbook, U.S. Department of Agriculture, Hyattsville, MD.
2. Daniel, E, M., Kropnick, A. S., Heur, Y. H., Blinzler, J. A., Nims, R. W., and Stoner, G. D. (1990) Extraction, stability and quantitation of ellagic acid in various fruits and nuts. J. Food Compos. Anal. 2, 338-349.
3. Lin, T. Y., and Vine, R. P. (1990) Identification and reduction of ellagic acid in muscadine grape juice. J. Food Sci. 55, 1607-1613.
4. Boukharta, M., Jalbert, G., and Castonguay, A. (1992) Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer 18, 181-189.
5. Miyamoto, K., Nomura, M., Murayama, T., Fumkawa, T., Hatano, T., Yoshida, T., Koshiura, R., and Okuda, T. (1993) Antitumor activities of ellagitannins against sarcoma-180 in mice. Biol. Pharm. Bull. 16, 379-387.
6. Castonguay, A., Gali, H. U., Perchellet, E. M., Gao, X. M., Boukharta, M., Jalbert, G., Okuda, T., Yoshida, T., Hatano, T., and Perchellet, J. P. (1997) Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligomeric anthocyanin and procyanidin. Int. J. Oncol. 10, 367-373.
7. Boukharta, M., Jalbert, G., and Castonguay, A. (1992) Efficacy of ellagitannins and ellagic acid as cancer chemopreventive agents. In Proceeding of International Conference of the Group Polyphenols, July 13-16, 1992, Lisbon, Portugal, Vol. 16, pp 245-249, Instaprint SA, Tours, France.
8. Daniel, E. M., Ratnayake, S., Kinstle, T., and Stoner, G. D. (1991) The effects of pH and rat intestinal contents on the liberation of ellagic acid from purified and crude ellagitannins J. Nat. Prod. 54, 946-952.
9. Mandai, S., and Stoner, G. D. (1990) Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11, 55-61.
10. Tanaka, T., Kojima, T., Kawamori, T., Wang, A., Suzui, M., Okamoto, K., and Mori, H. (1993) Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14, 1321-1325.
11. Tanaka, T., Iwata, H., Niwa, K., Mori, Y., and Mori, H. (1988) Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Jpn. J. Cancer Res. 79, 1297-1303.
12. Rao, C. V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G., and Reddy, B. S. (1991) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res. 51, 4528-4534.
13. Mukhtar, H., Das, M., and Bickers, D. R. (1986) Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Res. 46, 2262-2265.
14. Chang, R. L., Huang, M. T., Wood, A. W., Wong, C. Q., Newmark, H. L., Yagi, H., Sayer, J. M., Jerina, D. M., and Cooney, A. H. (1985) Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[α]pyrene and (±)-7β,8α-dihydroxy-9α,-10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis 6, 1127-1133.
15. Lesca, P. (1983) Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogenesis 4, 1651-1653.
16. Teel, R. W., and Martin, R. M. (1988) Disposition of the plant phenol ellagic acid in the mouse following oral administration by gavage. Xenobiotica 18, 397-405.
17. Smart, R. C., Huang, M. T., Chang, R. L., Sayer, J. M., Jerina, D. M., Wood, A. W., and Conney, A. H. (1986) Effect of ellagic acid and 3-O-decylellagic acid on the formation of benzo[a]pyrenederived DNA adducts in vivo and on the tumorigenicity of 3-methylcholanthrene in mice. Carcinogenesis 7, 1669-1675.
18. Smart, R. C., Huang, M. T., Chang, R. L., Sayer, J. M., Jerina, D. M., and Conney, A. H. (1986) Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3′-di-O-methylellagic acid in mice. Carcinogenesis 7, 1663-1667.
19. Heur, Y. H., Zeng, W., and Stoner, G. D. (1992) Synthesis of ellagic acid O-alkyl derivatives and isolation of ellagic acid as tetrahexanoyl derivative from Fragaria ananassa. J. Nat. Prod, 55, 1402- 1407.
20. Alo, B. I, Kandil, A., Paul, P. A., Sharp, M. J., Siddiqui, M. A., and Snieckus, V. (1991) Sequential directed ortho metalationboronic acid cross-coupling reactions. A general regiospecific route to oxygenated dibenzo[b,d]pyran-6-ones related to ellagic acid. J. Org. Chem. 56, 3763-3768.
21. Josephy, P. D., Lord, H. L., and Snieckus, V. A. (1990) Inhibition of benzo[a]pyrene dihydrodiol epoxide mutagenicity by synthetic analogues of ellagic acid. Mutat. Res. 142, 143-149.
22. Wilson, T., Lewis, M. J., Cha, K. L., and Gold, B. (1992) The effect of ellagic acid on xenobiotic metabolism by cytochrome P-450IIE1 and nitrosodimethylamine mutagenicity. Cancer Lett. 61, 129- 134.
23. Barch, D. H., Rundhaugen, L. M., Thomas, P. E., Kardos, P., and Pillay, N. S. (1994) Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA. Biochem. Biophys. Res. Commun. 201, 1477-1482.
24. Ahn, D., Putt, D., Kresty, L., Stoner, G. D., Fromm, D., and Hollenberg, P. F. (1996) The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P-450 and phase II enzymes. Carcinogenesis 17, 821-828.
25. Osawa, T., Ide, A., Su, J. D., and Namiki, M. (1987) Inhibition of lipid peroxidation by ellagic acid. J. Agric. Food Chem. 35, 808- 812.
26. Sayer, J. M., Yagi, H., Wood, A. W., Conney, A. H., and Jerina, D. M. (1982) Extremely facile reaction between the ultimate cocarcinogen benzo[a]pyrene-7,8-diol 9,10-eposide and ellagic acid. J. Am. Chem. Soc. 104, 5562-5564.
27. Dixit, R., and Gold, B. (1986) Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid. Proc. Natl, Acad. Sci. U.S.A. 83, 8039-8043.
28. Bhargava, U. C., and Westfall, B. A. (1968) Antitumor activity of Juglans nigra (Black Walnut) extractives. J. Pharm. Sci. 57, 1674-1677.
29. Hecht, S. S., Chen, C. B., Dong, M., Ornaf, R. M., Hoffmann, D., and Tso, T. C. (1977) Studies on nonvolatile nitrosamines in tobacco. Beitr. Tabakforsh. 9, 1-6.
30. Castonguay, A., Lin, D., Stoner, G. D., Radok, P., Furuya, K., Hecht, S. S., Schut, H. A. G., and Klaunig, J. E. (1983) Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res. 43, 1223-1229.
31. Charest, M., Rossignol, G., and Castonguay, A. (1989) In vitro and in vivo modulation of the bioactivation of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in hamster lung tissues. Chem.Biol. Interact, 71, 265-278.
32. Castonguay, A., Allaire, L., Charest, M., Rossignol, G., and Boutet, M. (1989) Metabolism of 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone by hamster respiratory tissues cultured with ellagic acid. Cancer Lett. 46, 93-105.
33. Maron, D. M., and Ames, B. N. (1983) Revised methods for the Salmonella mutagenicity assay. Mutat. Res. 113, 173-215.
34. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 192, 265-275.
35. Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R., and Mayer, R. T. (1994) Cytochrome P-450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem. Pharmacol. 48, 923-936.
36. Waxman, D. J., Ko, A., and Walsh, C. (1983) Regioselectivity and stereoselectivity of androgen hydroxylation catalyzed by cytochrome P-450 enzymes purified from PB induced rat liver. J. Biol. Chem. 258, 11937-11947.
37. Waxman, D. J. (1991) P-450 catalyzed steroid hydroxylation: assay and product identification by thin-layer chromatography. Methods Enzymol. 206, 462-476.
38. Teel, R., and Castonguay, A. (1992) Antimutagenic effects of polyphenolic compounds. Cancer Lett. 66, 107-113.
39. Castonguay, A., and Rioux, N. (1997) Inhibition of lung tumorigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis 18, 491-496.
40. Belinsky, S. A., Devereux, T. R., Foley, J. F., Maronpot, R. R., and Anderson, M. W. (1992) Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in the A/J mouse. Cancer Res. 52, 3164-3173.
41. Shimkin, M. B., and Stoner, G. D. (1975) Lung tumors in mice: application to carcinogenesis bioassay. Adv. Cancer Res. 21, 1-58.
42. Morse, M. A. (1998) Inhibition of NNK-induced lung carcinogenesis by modulators of NNK activation. Exp. Lung Res. 24, 595-604.
43. Fischer, S., Castonguay, A., Kaiserman, M., Spiegelhalder, B., and Preussmann, R. (1990) Tobacco-specific nitrosamines in Canadian cigarettes. J. Cancer Res. Clin. Oncol. 116, 563-568.
44. Brunnemann, K. D., Prokopczyk, B., Djordjevic, M. V., and Hoffmann, D. (1996) Formation and analysis of tobacco-specific N-nitrosamines. Crit. Rev. Toxicol. 26, 121-137.
45. Hoffmann, D., Rivenson, A., Murphy, S. E., Chung, F. L., Amin, S., and Hecht, S. S. (1993) Cigarette smoking and adenocarcinoma of the lung: the relevance of nicotine-derived N-nitrosamines. Smoking-Related Disease 4, 165-189.
46. Pepin, P., Rossignol, G., and Castonguay, A. (1990) Inhibition of NNK-induced lung tumorigenesis in A/J mice by ellagic acid and butylated hydroxyanisole. Cancer J. 3, 266-273.
47. Bouchard, L., and Castonguay, A. (1993) Inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the metabo-lism of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK)in mouse lung expiants. Drug Metab. Dispos. 21, 293-298.
48. Zhang, Z., Hamilton, S. M., Stewart, C., Strother, A., and Teel, R. W. (1993) Inhibition of liver microsomal cytochrome P-450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 13, 2341-2346.
49. 6alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 10, 562- 567.
50. 6-methylguanine is a critical determinant of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51, 5557- 5564.
51. Hecht, S. S., Lin, D., and Castonguay, A. (1983) Effects of α-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK). Carcinogenesis 4, 305- 310.
52. Smith, T. J., Stoner, G. D., and Yang, C. S. (1995) Activation of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res. 55, 5566-5573.
53. Smith, T. J., Guo, Z., Li, C., Ning, S. M., Thomas, P. E., and Yang, C. S. (1993) Mechanisms of inhibition of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Cancer Res. 53, 3276-3282.
54. Smith, T. J., Guo, Z., Thomas, P. E., Chung, F. L., Morse, M. A., Elkind, K., and Yang, C. S. (1990) Metabolism of 4-(methylnit-rosamino)-l-(3-pyridyl)-l-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res. 50, 6817-6822.
55. Forkert, P. G., Parkinson, A., Thaete, L. G., and Malkinson, A. M. (1992) Resistance of murine lung tumors to xenobiotic-induced cytotoxicity. Cancer Res. 52, 6797-6803.
56. Guo, Z., Smith, T. J., Ishizaki, H., and Yang, C. S. (1991) Metabolism of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) by cytochrome P450 IIB1 in a reconstituted system. Carcinogenesis 12, 2277-2282.
57. Guo, Z., Wang, M., Tian, G., Burger, J., Gochfeld, M., and Yang, C. S. (1993) Age- and gender-related variations in the activities of drug-metabolizing and antioxidant enzymes in the white-footed mouse (Peromyscus leucopus). Growth, Dev. Aging 57, 85-100.
58. Lamoureux, J., and Castonguay, A. (1997) Absence of metabolism of 4-(methylnitrosammo)-l-(3-pyridyl)-l-butanone (NNK) by flavin-containing monooxygenase (FMO). Carcinogenesis 18, 1979-1984.